Konstantinos Karatzas

Founder at

Acesis Holdings Corp.

67 year

Consumer Services

Technology Services

Health Technology

Profile

Dr. Konstantinos Karatzas is a Chief Executive Officer & Director at Acesis Holdings Corp.
He is on the Board of Directors at Acesis Holdings Corp.
and Applied Biotech Intelligence.
Dr. Karatzas was previously employed as a Chief Executive Officer by Acesis, Inc. He received his undergraduate degree from National & Kapodistrian University of Athens, a graduate degree from McGill University and an MBA from McGill University.

Konstantinos Karatzas active positions

Companies	Position	Start
Acesis Holdings Corp. Acesis Holdings Corp. BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders	Founder	02/10/2022
Applied Biotech Intelligence	Director/Board Member	31/12/2014

All active positions of Konstantinos Karatzas

Former positions of Konstantinos Karatzas

Companies	Position	End
Acesis, Inc. Acesis, Inc. Packaged SoftwareTechnology Services Develops software solutions that offers data capture forms for physicians	Chief Executive Officer	-

See the detail of Konstantinos Karatzas's experience

Training of Konstantinos Karatzas

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Konstantinos Karatzas's experience

Linked companies

Private companies	5
Acesis, Inc. Acesis, Inc. Packaged SoftwareTechnology Services Develops software solutions that offers data capture forms for physicians	Technology Services
McGill University McGill University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
National & Kapodistrian University of Athens National & Kapodistrian University of Athens Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Acesis Holdings Corp. Acesis Holdings Corp. BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders	Health Technology
Applied Biotech Intelligence